DJIA52361.58 146.42
S&P 5007676.77 53.09
NASDAQ26169.38 214.04
Russell 20002786.42 10.53
German DAX25440.83 259.18
FTSE 10010767.33 76.97
CAC 407847.32 64.50
EuroStoxx 506113.05 47.90
Nikkei 22562189.65 -503.51
Hang Seng23211.81 118.44
Shanghai Comp3697.52 7.04
KOSPI5469.47 -80.83
Bloomberg Comm IDX142.94 -0.75
WTI Crude-fut115.26 -1.65
Brent Crude-fut102.00 -1.71
Natural Gas3.54 0.91
Gasoline-fut3.13 -0.09
Gold-fut4026.00 16.00
Silver-fut53.99 0.03
Platinum-fut1533.10 -22.70
Palladium-fut1046.50 0.00
Copper-fut6.55 0.05
Aluminum-spot3195.00 0.00
Coffee-fut299.50 -6.50
Soybeans-fut1253.50 -16.00
Wheat-fut615.50 -9.50
Bitcoin79899.94 -1155.11
Ethereum USD2307.35 -75.41
Litecoin56.45 -1.12
Dogecoin0.08 0.00
EUR/USD1.1174 -0.0032
USD/JPY157.62 0.71
GBP/USD1.3347 -0.0028
USD/CHF0.8278 0.0020
USD IDX102.02 0.27
US 10-Yr TR4.965 -0.021
GER 10-Yr TR3.3699 0.015
UK 10-Yr TR5.3517 0.0043
JAP 10-Yr TR2.791 0.004
Fed Funds4 0
SOFR3.92 0.02
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + Private Equity  | 
Avista Capital Closes $1.5B Healthtech Fund

Avista Capital Closes $1.5B Healthtech Fund

Avista Capital Partners, a NY-based healthcare-focused private equity firm, announced the final closing of its sixth fund, Avista Healthcare Partners VI, at $1.5 billion. The fund surpassed its $1.25 billion target,

The fund builds on the firm’s strategy of investing in high-growth middle-market products and healthtech companies in North America and Europe.

“The closing of Fund VI is an endorsement of our long-held strategy of identifying and accelerating growth-oriented healthcare businesses with strong secular tailwinds,” said David Burgstahler, Avista CEO.

The firm’s core healthcare sub-sectors include outsourced pharma & medtech services, consumer healthcare, medical devices, specialty & generic pharmaceuticals, distribution and diagnostics, and healthcare technology.

Fund VI is the third dedicated healthcare fund for Avista and has already made five healthcare platform investments.

Founded in 2005, Avista Capital has invested more than $8 billion in over 45 growth-oriented healthcare businesses globally.

Connect

Inside The Story

Avista Capital Partners

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.